Cargando…

Impact of intrauterine exposure to maternal diabetes on preterm birth: fetal DNA methylation alteration is an important mediator

BACKGROUND: In utero exposure to diabetes has been shown to contribute to preterm birth, though the underlying biological mechanisms are yet to be fully elucidated. Fetal epigenetic variations established in utero may be a possible pathway. This study aimed to investigate whether in utero exposure t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guoying, Xu, Richard, Zhang, Boyang, Hong, Xiumei, Bartell, Tami R., Pearson, Colleen, Liang, Liming, Wang, Xiaobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082529/
https://www.ncbi.nlm.nih.gov/pubmed/37029435
http://dx.doi.org/10.1186/s13148-023-01473-1
_version_ 1785021331797966848
author Wang, Guoying
Xu, Richard
Zhang, Boyang
Hong, Xiumei
Bartell, Tami R.
Pearson, Colleen
Liang, Liming
Wang, Xiaobin
author_facet Wang, Guoying
Xu, Richard
Zhang, Boyang
Hong, Xiumei
Bartell, Tami R.
Pearson, Colleen
Liang, Liming
Wang, Xiaobin
author_sort Wang, Guoying
collection PubMed
description BACKGROUND: In utero exposure to diabetes has been shown to contribute to preterm birth, though the underlying biological mechanisms are yet to be fully elucidated. Fetal epigenetic variations established in utero may be a possible pathway. This study aimed to investigate whether in utero exposure to diabetes was associated with a change in newborn DNA methylation, and whether the identified CpG sites mediate the association between diabetes and preterm birth in a racially diverse birth cohort population. METHODS: This study included 954 mother–newborn pairs. Methylation levels in the cord blood were determined using the Illumina Infinium MethylationEPIC BeadChip 850 K array platform. In utero exposure to diabetes was defined by the presence of maternal pregestational or gestational diabetes. Preterm birth was defined as gestational age at birth less than 37 weeks. Linear regression analysis was employed to identify differentially methylated CpG sites. Differentially methylated regions were identified using the DMRcate Package. RESULTS: 126 (13%) newborns were born to mothers with diabetes in pregnancy and 173 (18%) newborns were born preterm, while 41 newborns were born both preterm and to mothers with diabetes in pregnancy. Genomic-wide CpG analysis found that eighteen CpG sites in cord blood were differentially methylated by maternal diabetes status at an FDR threshold of 5%. These significant CpG sites were mapped to 12 known genes, one of which was annotated to gene Major Histocompatibility Complex, Class II, DM Beta (HLA-DMB). Consistently, one of the two identified significant methylated regions overlapped with HLA-DMB. The identified differentially methylated CpG sites mediated the association between diabetes in pregnancy and preterm birth by 61%. CONCLUSIONS: In this US birth cohort, we found that maternal diabetes was associated with altered fetal DNA methylation patterns, which substantially explained the link between diabetes and preterm birth. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-023-01473-1.
format Online
Article
Text
id pubmed-10082529
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100825292023-04-09 Impact of intrauterine exposure to maternal diabetes on preterm birth: fetal DNA methylation alteration is an important mediator Wang, Guoying Xu, Richard Zhang, Boyang Hong, Xiumei Bartell, Tami R. Pearson, Colleen Liang, Liming Wang, Xiaobin Clin Epigenetics Research BACKGROUND: In utero exposure to diabetes has been shown to contribute to preterm birth, though the underlying biological mechanisms are yet to be fully elucidated. Fetal epigenetic variations established in utero may be a possible pathway. This study aimed to investigate whether in utero exposure to diabetes was associated with a change in newborn DNA methylation, and whether the identified CpG sites mediate the association between diabetes and preterm birth in a racially diverse birth cohort population. METHODS: This study included 954 mother–newborn pairs. Methylation levels in the cord blood were determined using the Illumina Infinium MethylationEPIC BeadChip 850 K array platform. In utero exposure to diabetes was defined by the presence of maternal pregestational or gestational diabetes. Preterm birth was defined as gestational age at birth less than 37 weeks. Linear regression analysis was employed to identify differentially methylated CpG sites. Differentially methylated regions were identified using the DMRcate Package. RESULTS: 126 (13%) newborns were born to mothers with diabetes in pregnancy and 173 (18%) newborns were born preterm, while 41 newborns were born both preterm and to mothers with diabetes in pregnancy. Genomic-wide CpG analysis found that eighteen CpG sites in cord blood were differentially methylated by maternal diabetes status at an FDR threshold of 5%. These significant CpG sites were mapped to 12 known genes, one of which was annotated to gene Major Histocompatibility Complex, Class II, DM Beta (HLA-DMB). Consistently, one of the two identified significant methylated regions overlapped with HLA-DMB. The identified differentially methylated CpG sites mediated the association between diabetes in pregnancy and preterm birth by 61%. CONCLUSIONS: In this US birth cohort, we found that maternal diabetes was associated with altered fetal DNA methylation patterns, which substantially explained the link between diabetes and preterm birth. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-023-01473-1. BioMed Central 2023-04-07 /pmc/articles/PMC10082529/ /pubmed/37029435 http://dx.doi.org/10.1186/s13148-023-01473-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Guoying
Xu, Richard
Zhang, Boyang
Hong, Xiumei
Bartell, Tami R.
Pearson, Colleen
Liang, Liming
Wang, Xiaobin
Impact of intrauterine exposure to maternal diabetes on preterm birth: fetal DNA methylation alteration is an important mediator
title Impact of intrauterine exposure to maternal diabetes on preterm birth: fetal DNA methylation alteration is an important mediator
title_full Impact of intrauterine exposure to maternal diabetes on preterm birth: fetal DNA methylation alteration is an important mediator
title_fullStr Impact of intrauterine exposure to maternal diabetes on preterm birth: fetal DNA methylation alteration is an important mediator
title_full_unstemmed Impact of intrauterine exposure to maternal diabetes on preterm birth: fetal DNA methylation alteration is an important mediator
title_short Impact of intrauterine exposure to maternal diabetes on preterm birth: fetal DNA methylation alteration is an important mediator
title_sort impact of intrauterine exposure to maternal diabetes on preterm birth: fetal dna methylation alteration is an important mediator
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082529/
https://www.ncbi.nlm.nih.gov/pubmed/37029435
http://dx.doi.org/10.1186/s13148-023-01473-1
work_keys_str_mv AT wangguoying impactofintrauterineexposuretomaternaldiabetesonpretermbirthfetaldnamethylationalterationisanimportantmediator
AT xurichard impactofintrauterineexposuretomaternaldiabetesonpretermbirthfetaldnamethylationalterationisanimportantmediator
AT zhangboyang impactofintrauterineexposuretomaternaldiabetesonpretermbirthfetaldnamethylationalterationisanimportantmediator
AT hongxiumei impactofintrauterineexposuretomaternaldiabetesonpretermbirthfetaldnamethylationalterationisanimportantmediator
AT bartelltamir impactofintrauterineexposuretomaternaldiabetesonpretermbirthfetaldnamethylationalterationisanimportantmediator
AT pearsoncolleen impactofintrauterineexposuretomaternaldiabetesonpretermbirthfetaldnamethylationalterationisanimportantmediator
AT liangliming impactofintrauterineexposuretomaternaldiabetesonpretermbirthfetaldnamethylationalterationisanimportantmediator
AT wangxiaobin impactofintrauterineexposuretomaternaldiabetesonpretermbirthfetaldnamethylationalterationisanimportantmediator